Caffeine Increases Maximal Fat Oxidation During Exercise in Endurance-trained Men: is There a Diurnal Variation

NCT ID: NCT04320446

Last Updated: 2020-03-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

15 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-06-01

Study Completion Date

2019-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Maximal fat oxidation during exercise (MFO) and the intensity of exercise that elicits MFO (Fatmax) has been recognized as potential determinants of endurance performance.

The purpose of this study was to determine the possible interaction between the effects of diurnal variation (morning vs. afternoon) and caffeine ingestion on MFO, Fatmax and VO2 max in endurance-trained men. Specifically, the investigators sought to elucidate whether the stimulant actions of caffeine could reverse the decrements of MFO and Fatmax observed in the morning.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Body weight, height, body composition (DXA), exercise test (MFO and VO2max assessment) will be measured during the 4 evaluations.

Participants were randomized into 4 exercise test conditions:

1. Exercise test in the morning with placebo intake
2. Exercise test in the evening with placebo intake
3. Exercise test in the morning with caffeine intake
4. Execrise test in the evening with caffeine intake

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Energy Metabolism Athletic Performance

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

OTHER

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Caffeine

A dose of 3 mg/kg of caffeine (i.e. a vegetable extraction from green coffee beans, Harrison Sport Nutrition®, Spain) was ingested before the beginning of each test.

Group Type EXPERIMENTAL

Test in the morning

Intervention Type BEHAVIORAL

The exercise test was performed between 8 a.m and 11 a.m

Test in the afternoon

Intervention Type BEHAVIORAL

The exercise test was performed between 5 p.m. and 8 p.m.a

Placebo

A dose of 3 mg/kg of placebo (i.e. 100% purity microcrystalline cellulose, Acofarma, Spain) was ingested before the beginning of each test.

Group Type PLACEBO_COMPARATOR

Test in the morning

Intervention Type BEHAVIORAL

The exercise test was performed between 8 a.m and 11 a.m

Test in the afternoon

Intervention Type BEHAVIORAL

The exercise test was performed between 5 p.m. and 8 p.m.a

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Test in the morning

The exercise test was performed between 8 a.m and 11 a.m

Intervention Type BEHAVIORAL

Test in the afternoon

The exercise test was performed between 5 p.m. and 8 p.m.a

Intervention Type BEHAVIORAL

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

MFO-morning, Fatmax-morning, and VO2max-morning (MFO-afternoon, Fatmax-afternoon, and VO2max-afternoon

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Having a body mass index (BMI) ranged from 18.5 to 28 kg/m2
* not suffering any specific disease which can be aggravated by physical exercise
* having previous experience in endurance training (i.e. self-reporting at least 2 years of cycling or running training including more than 3 training sessions/week).

Exclusion Criteria

* Being smoker
* Taking medication or drugs
* Any non-controlled medical condition which could influence results or could be worsened by the participation in the study
* Are deemed unsuitable by the investigator for any other reason, that prevent data collection.
Minimum Eligible Age

18 Years

Maximum Eligible Age

40 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Universidad de Granada

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Jonatan Ruiz Ruiz

Associate professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jonatan Ruiz Ruiz, Dr.

Role: PRINCIPAL_INVESTIGATOR

Universidad de Granada

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Instituto Mixto Universitario Deporte Salud

Granada, , Spain

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Spain

References

Explore related publications, articles, or registry entries linked to this study.

Ramirez-Maldonado M, Jurado-Fasoli L, Del Coso J, R Ruiz J, Amaro-Gahete FJ. Caffeine increases maximal fat oxidation during a graded exercise test: is there a diurnal variation? J Int Soc Sports Nutr. 2021 Jan 7;18(1):5. doi: 10.1186/s12970-020-00400-6.

Reference Type DERIVED
PMID: 33413459 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Nº 507/CEIH/2018

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Caffeine and Intermittent Claudication
NCT00388128 COMPLETED PHASE3
Caffeine and Cerebrovascular Reactivity
NCT04730193 COMPLETED EARLY_PHASE1